Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators.
Rossing P, et al.
Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294.
Diabetes Care. 2022.
PMID: 35972218
Free PMC article.
Clinical Trial.